Skip to content
Specimen Atlas of Research Peptides30 plates · MIT
Side-by-side · Research reference

KPVvsSemax

Side-by-side comparison across mechanism, dosage, evidence, side effects, administration, and stack synergies. Citations on every claim where available.

AAnimal-StrongDraft13/39 cited
BHuman-MechanisticDraft12/39 cited
KPV
α-MSH C-terminal · Anti-inflammatory
200–500 mcgDaily doseDalle-Pang 2024
AnimalEvidence levelDalle-Pang 2024
HoursHalf-life (est)
SQ / oral / topical · Local · Daily or 2-3×/week
Semax
Cognitive enhancer · Russian Pharma
200–600 mcg/doseIntranasalKaplan 2017
HumanMechanisticKaplan 2017
~30 minOnset
Intranasal · 2–3×/day during cognitive demand

01Mechanism of Action

Parameter
KPV
Semax
Primary target
Intracellular targets bypassing melanocortin receptors (proposed)Dalle-Pang 2024
BDNF / NGF expression + monoamine modulationKaplan 2017
Pathway
NF-κB inhibition + cytokine modulation (TNF-α, IL-1β, IL-6) → reduced inflammationDalle-Pang 2024
↑ BDNF + NGF synthesis + 5-HT modulation → neuroplasticity + anxiolysis + cognitive enhancementKaplan 2017
Downstream effect
Anti-inflammatory action without α-MSH pigmentation effects; gut barrier protectionDalle-Pang 2024
Improved memory + attention; reduced anxiety; neuroprotection in ischemiaKaplan 2017
Feedback intact?
No melanocortin receptor binding
Origin
Synthetic tripeptide; the C-terminal Lys-Pro-Val residues of α-MSH (residues 11-13)Dalle-Pang 2024
Synthetic 7-AA peptide derived from ACTH(4-7) with C-terminal Pro-Gly-Pro stabilising tailKaplan 2017
Antibody development

02Dosage Protocols

Parameter
KPV
Semax
Standard dose
200–500 mcg / day SQ or oralDalle-Pang 2024
200–600 mcg / dose intranasalKaplan 2017
Frequency
Daily or 2–3× per week
2–3× per day during cognitive demand
Lower / starter dose
100 mcg / day
100 mcg / dose
Evidence basis
Animal-strong + emerging clinical data in IBDDalle-Pang 2024
Human-mechanistic + Russian clinicalKaplan 2017
Duration
4–8 weeks per cycle
10–14 day cycles, repeated PRN
Reconstitution
Bacteriostatic water (SQ form)
Pre-formulated nasal spray (commercial); research vial: bacteriostatic water
Timing
No specific time; often taken with / before meals (oral)
Morning + early afternoon
Half-life
Hours (estimated; rapid tissue uptake)
Short plasma; CNS effect lasts ~3–6 hr

04Side Effects & Safety

Parameter
KPV
Semax
Injection site reaction
Mild irritation
GI symptoms
Rare nausea (oral form)
Pigmentation
None (unlike full α-MSH)Dalle-Pang 2024
Long-term safety
Limited human data
Limited Western RCT data
Pregnancy / OB
Avoid — insufficient data
Avoid
Nasal irritation
Mild burning or congestion (transient)
Sleep disruption
Late-day dosing may interfere with sleep
Headache
Uncommon, transient
Absolute Contraindications
KPV
  • ·Pregnancy / breastfeeding
Semax
  • ·Pregnancy / breastfeeding
Relative Contraindications
KPV
  • ·Active autoimmune disease (theoretical)
Semax
  • ·Active psychiatric instability
  • ·Concurrent strong stimulants

05Administration Protocol

Parameter
KPV
Semax
1. Reconstitution
Add 1 mL bacteriostatic water to vial per labelling.
Pre-formulated nasal spray (commercial) or research vial reconstituted with bacteriostatic water.
2. Form
SQ injection (acute), oral capsule (chronic / gut), topical for skin indications.
Intranasal — 2–3 sprays per nostril per dose. Tilt head slightly back.
3. Timing
Morning preferred; oral form taken with / before meals.
Morning + early afternoon. Avoid evening (sleep disruption).
4. Storage
Lyophilised: room temp, light-protected. Reconstituted: refrigerate ≤30 days.
Refrigerate after reconstitution; light-protected.
5. Needle
29–31G insulin syringe (SQ form).
Cycle on/off to avoid neurochemical adaptation.

06Stack Synergy

KPV
+ BPC-157
Strong
View BPC-157

KPV (NF-κB inhibition, cytokine reduction) + BPC-157 (VEGF-driven angiogenesis, tissue regeneration) form the classic gut-healing stack. KPV reduces inflammatory drive; BPC-157 promotes mucosal repair. Anecdotally favoured for IBD, ulcerative colitis, and post-surgical gut recovery.

KPV
200–500 mcg oral · daily
BPC-157
250–500 mcg oral or SQ · daily
Primary benefit
Combined anti-inflammation + mucosal repair for gut conditions
Semax
+ Selank
Moderate
View Selank

Semax (cognitive enhancer, BDNF/NGF) and Selank (anxiolytic + immune) form the canonical Russian "neuro stack" — both intranasal peptide bioregulators with complementary axes. Semax for cognitive demand; Selank for stress mitigation.

Semax
200–600 mcg intranasal · morning + afternoon
Selank
150–300 mcg intranasal · midday + early evening
Primary benefit
Cognitive enhancement + stress mitigation